Bifogade filer
Download selskabsmeddelelse.pdf
Beskrivning
| Land | Danmark |
|---|---|
| Lista | First North Denmark |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
30.1.2025 12:49:48 CET | BactiQuant A/S | Periodeoplysning
Salget i 4. kvartal 2024 udviklede sig særdeles positivt. I november og december modtog BactiQuant flere ordrer i millionklassen, bl.a. på i alt 8 stk. online-robotprøvetagere til Pharma-segmentet og på 4 stk. online-robotprøvetagere til forsyningsselskabet Verdo. Ordrerne kom dog så sent på året, at de kun i begrænset omfang har påvirket omsætningen i 2024. Til gengæld danner de, sammen med en solid ordrebeholdning og pipeline, et rigtig godt grundlag for den forventede markante omsætningsvækst i 2025.
BactiQuant udsender hermed trading statement Q4 2024. Trading statement for Q4 kan læses i sin helhed i det vedhæftede pdf-dokument.
Kontakter
- Henrik Enegaard Skaanderup, Bestyrelsesformand, +4540334470, henrik-skaanderup@mail.dk
- Henrik Sønderup Sørensen, CFO, BactiQuant AS, +4569884000, +4569884002, hss@bactiquant.com
- John Norden, Certificeret rådgiver til Nasdaq First North, +4520700200, jn@nordencef.dk
- Morten Miller, Chief Executive Officer CEO/CINO, +4523678732, miller@bactiquant.dk
Om BactiQuant A/S
Bactiquant has developed a technology that will revolutionize the monitoring of bacterial contamination levels in water and ensure optimum usage and handling of water around the world to the benefit of our customers and the sustainability of our planet. To show our environmental commitment, we have aligned our business with four of the UN's Sustainable Development Goals. We believe that Bactiquant will be the world leader within mobile and online surveillance of bacterial contamination levels, and we are already well on our way. Headquartered in Denmark and operating across five continents, our customers come from a wide range of industries such as public water utility companies, industries needing water cooling or requiring wastewater treatment, and aquaculture.